A binuclear aluminium complex as a single competent catalyst for efficient synthesis of urea, biuret, isourea, isothiourea, phosphorylguanidine, and quinazolinones

The synthesis and characterisation of two mononuclear aluminium alkyl complexes with the general composition [Al(Me)2{Ph2P(E)N(CH2)2N(CH2CH2)2O}] (E = Se (2a); S (2b)), and two binuclear aluminium complexes, [Al(Me)2{Ph2P-(E)N(CH2)2N(CH2CH2)2O}(AlMe3)] (E = Se (3a) and S (3b)), are described. The binuclear aluminium alkyl complex 3a proved to be a proficient catalyst for the addition of simple nucleophiles to heterocumulenes, leading to the synthesis of a variety of products such as urea, biuret, isourea, isothiourea, phosphorylguanidine, and quinazolinone derivatives, in contrast to its mononuclear analogues. Complex 3a is the first example of a single competent catalyst, which is also low-cost and eco-friendly and derived from a main-group metal, under solvent-free conditions either at room temperature or mild temperatures. Complex 3a possessed a wide functional group tolerance including heteroatoms, yielding the corresponding insertion products in good quantities and with high selectivity.

Molecular Capacitors: Accessible 6- and 8-Electron Redox Chemistry from Dimeric "Ti(I)" and "Ti(0)" Synthons Supported by Imidazolin-2-Iminato Ligands

Reduction of the diamagnetic Ti(III)/Ti(III) dimer [Cl₂Ti(μ-NIm^Dipp)]₂ (1) (NIm^Dipp = [1,3-bis(Dipp)imidazolin-2-iminato]^-, Dipp = C₆H₃-2,6-ⁱPr₂) with 4 and 6 equiv of KC₈ generates the intramolecularly arene-masked, dinuclear titanium compounds [(μ-N-η⁶-Im^Dipp)Ti]₂ (2) and {[(Et₂O)₂K](μ-N-μ-η⁶:η⁶-Im^Dipp)Ti}₂ (3), respectively, in modest yields. The compounds have been structurally characterized by X-ray crystallographic analysis, and inspection of the bond metrics within the η⁶-coordinated aryl substituent of the bridging imidazolin-2-iminato ligand shows perturbation of the aromatic system most consistent with two-electron reduction of the ring. As such, 2 and 3 can be assigned respectively as possessing metal centers in formal Ti(III)/Ti(III) and Ti(II)/Ti(II) oxidation states. Exploration of their redox chemistry reveal the ability to reduce several substrate equivalents. For instance, treatment of 2 with excess C₈H₈ (COT) forms the novel COT-bridged complex [(Im^DippN)(η⁸-COT)Ti](μ-η²:η³-COT)[Ti(η⁴-COT)(NIm^Dipp)] (4) that dissociates in THF solutions to give mononuclear (Im^DippN)Ti(η⁸-COT)(THF) (5). Addition of COT to 3 yields heterometallic [(Im^DippN)(η⁴-COT)Ti(μ-η⁴:η⁵-COT)K(THF)(μ-η⁶:η⁴-COT)Ti(NIm^Dipp)(μ-η⁴:η⁴-COT)K(THF)₂]_n (6). Compounds 4 and 5 are the products of the 4-electron oxidation of 2, while 6 stands as the 8-electron oxidation product of 3. Reduction of organozides was also explored. Low temperature reaction of 2 with 4 equiv of AdN₃ gives the terminal and bridged imido complex [(Im^DippN)Ti(═NAd)](μ-NAd)₂[Ti(NIm^Dipp)(N₃Ad)] (7) that undergoes intermolecular C-H activation of toluene at room temperature to afford the amido compound [(Im^DippN)Ti(NHAd)](μ-NAd)₂[Ti(C₆H₄Me)(NIm^Dipp)] (8-tol). These complexes are the 6-electron oxidation products of the reaction of 2 with AdN₃. Furthermore, treatment of 3 with 4 equiv of AdN₃ produces the thermally stable Ti(III)/Ti(III) terminal and bridged imido [K(18-crown-6)(THF)₂]{[(Im^DippN)Ti(NAd)](μ-NAd)₂K[Ti(NIm^Dipp)]} (10). Altogether, these reactions firmly establish 2 and 3 as unprecedented Ti(I)/Ti(I) and Ti(0)/Ti(0) synthons with the clear capacity to effect multielectron reductions ranging from 4 to 8 electrons.

Titanium complexes with unsymmetrically substituted imidazolin-2-iminato ligands

The reaction of the unsymmetrical N-heterocyclic carbenes 1-(2,4,6-trimethylphenyl)-3-(adamantyl)imidazolin-2-ylidene (IAdMes, 1a) and 1-(2,6-diisopropylphenyl)-3-(adamantyl)imidazolin-2-ylidene (IAdDipp, 1b) with trimethylsilyl azide furnished the 2-(trimethylsilylimino)imidazolines 2a (Im^AdMesNSiMe₃) and 2b (Im^AdDippNSiMe₃). Desilylation by stirring in methanol gave the corresponding imidazolin-2-imines 3a (Im^AdMesNH) and 3b (Im^AdDippNH). 2a and 2b were treated with [TiCl₄(THF)₂] (THF = tetrahydrofuran) and [CpTiCl₃] (Cp = η⁵-C₅H₅) to form the mono- and bis(imidazolin-2-iminato) titanium(IV) complexes [(Im^AdRN)TiCl₃] (4, R = Mes, Dipp), [Cp(Im^AdRN)TiCl₂] (5, R = Mes, Dipp), and [(Im^AdRN)₂TiCl₂] (6, R = Mes, Dipp). The crystal structures of all compounds except 2b were determined by X-ray diffraction analysis.

Aluminium alkyl complexes supported by imino-phosphanamide ligand as precursors for catalytic guanylation reactions of carbodiimides

Herein, we report the synthesis, characterisation, and application of three aluminium alkyl complexes, [κ2-{NHIRP(Ph)NDipp}AlMe2] (R = Dipp (2a), Mes (2b); tBu (2c), Dipp = 2,6-diisopropylphenyl, Mes = mesityl, and tBu = tert-butyl), supported by unsymmetrical imino-phosphanamide [NHIRP(Ph)NDipp]- [R = Dipp (1a), Mes (1b), tBu (1c)] ligands as molecular precursors for the catalytic synthesis of guanidines using carbodiimides and primary amines. All the imino-phosphanamide ligands 1a, 1b and 1c were prepared in good yield from the corresponding N-heterocyclic imine (NHI) with phenylchloro-2,6-diisopropylphenylphosphanamine, PhP(Cl)NHDipp. The aluminium alkyl complexes 2a, 2b and 2c were obtained in good yield upon completion of the reaction between trimethyl aluminium and the protic ligands 1a, 1b and 1c in a 1 : 1 molar ratio in toluene via the elimination of methane, respectively. The molecular structures of the protic ligands 1b and 1c and the aluminium complexes 2a, 2b and 2c were established via single-crystal X-ray diffraction analysis. Complexes 2a, 2b and 2c were tested as pre-catalysts for the hydroamination/guanylation reaction of carbodiimides with aryl amines to afford guanidines at ambient temperature. All the aluminium complexes exhibited a high conversion with 1.5 mol% catalyst loading and broad substrate scope with a wide functional group tolerance during the guanylation reaction. We also proposed the most plausible mechanism, involving the formation of catalytically active three-coordinate Al species as the active pre-catalyst.

Recent developments in highly basic N-heterocyclic iminato ligands in actinide chemistry

In the last decade, major conceptual advances in the chemistry of actinide molecules and materials have been made to demonstrate their distinct reactivity profiles as compared to lanthanide and transition metal compounds, but some difficult questions remain concerning the intriguing stability of low-valent actinide complexes, and the importance of the 5f-orbitals in reactivity and bonding. The imidazolin-2-iminato moiety has been extensively used in ligands for the advancement of actinide chemistry owing to its unique capability of stabilizing the reactive and highly electrophilic metal ions by virtue of its strong electron donation and steric tunability. The current review article describes recent developments in the chemistry of light actinide metal ions (thorium and uranium) bearing these N-heterocyclic iminato moieties as supporting ligands. In addition, the effect of ring expansion of the N-heterocycle on the catalytic aptitude of the organoactinides is also described herein. The synthesis and reactivity of actinide complexes bearing N-heterocyclic iminato ligands are presented, and promising apposite applications are also presented. The current review focuses on addressing the catalytic behavior of actinide complexes with oxygen-containing substrates such as in the Tishchenko reaction, hydroelementation processes, and polymerization reactions. Actinide complexes have also found new catalytic applications, as demonstrated by the potent chemoselective carbonyl hydroboration and tandem proton-transfer esterification (TPTE) reaction, featuring coupling between an aldehyde and alcohol.

Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition

A series of novel quinazolinone derivatives (2–13) was synthesized and examined for their cytotoxicity to HepG2, MCF-7, and Caco-2 in an MTT assay. Among these derivatives, compounds 4 and 9 exhibited significant cytotoxic activity against Caco-2, HepG2, and MCF-7 cancer cells. Compound 4 had more significant inhibitory effects than compound 9 on Caco-2, HepG2, and MCF-7 cell lines, with IC₅₀ values of 23.31 ± 0.09, 53.29 ± 0.25, and 72.22 ± 0.14µM, respectively. The AKT pathway is one of human cancer’s most often deregulated signals. AKT is also overexpressed in human cancers such as glioma, lung, breast, ovarian, gastric, and pancreas. A molecular docking study was performed to analyze the inhibitory action of newly synthetic quinazolinone derivatives against Homo sapiens AKT1 protein. Molecular docking simulations were found to be in accordance with in vitro studies, and hence supported the biological activity. The results suggested that compounds 4 and 9 could be used as drug candidates for cancer therapy via its potential inhibition of AKT1 as described by docking study.

An imidazolin-2-iminato ligand organozinc complex as a catalyst for hydroboration of organic nitriles

Catalytic hydroboration of nitriles with pinacolborane (HBpin) using the imidazolin-2-iminato zinc alkyl complex [{(Im^tBuN)Zn(CH₂CH₃)}₂] (1c) under mild and solvent-free conditions to afford corresponding diboronate esters in high yield is reported.